Advisornet Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Advisornet Financial's JAZZ Position: Q2 2026 in Review
Advisornet Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 3,433% in Q2 2026, buying an estimated $22.6K and bringing the position to 106 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.
Advisornet Financial first reported a position in JAZZ in Q3 2019 and has held it in 23 quarters since. The position peaked at $152K in Q4 2019. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Advisornet Financial held 106 shares of Jazz Pharmaceuticals worth $25.5K as of Q2 2026.
- Advisornet Financial bought 103 Jazz Pharmaceuticals shares in Q2 2026, an estimated $22.6K.
- Jazz Pharmaceuticals made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1316 holding.
- Advisornet Financial first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 23 quarters since.
- Advisornet Financial's Jazz Pharmaceuticals position peaked at $152K in Q4 2019.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.